- Thrombin-receptor antagonist vorapaxar in acute coronary syndromes2012 | Third Faculty of Medicine
- Clopidogrel, prasugrel, ticagrelor or vorapaxar in patients with renal impairment: do we have a winner?2015 | Second Faculty of Medicine
- Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes2012 | Publication without faculty affiliation
- Usefulness and Safety of Vorapaxar in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (from the TRACER Trial)2014 | Third Faculty of Medicine
- The Impact of Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies with and without Apheresis on Platelet Aggregation in Familial Hypercholesterolemia2024 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Survival After Solid Cancers in Antithrombotic Trials2015 | Second Faculty of Medicine
- Sex-Related Differences in Platelet Aggregation: A Literature Review Supplemented with Local Data from a Group of Generally Healthy Individuals2023 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Protease-Activated Receptors: Activation, Inhibition and Pharmaceutical Relevance2015 | First Faculty of Medicine
- Antiplatelet therapy - A pharmacologist's perspective2013 | Third Faculty of Medicine